The effect of axial length on laser spot size and laser irradiance.
OBJECTIVE
To determine the effect of the axial length of the eye on laser spot size and irradiance.


METHODS
Experimental study using a calibrated Gullstrand-type model eye.


METHODS
The model eye, which was fitted with a scale of half circles in the center of the artificial fundus, was first examined using 2 different fundus imaging systems, then with a setup of a slitlamp, 2 indirect condensing laser lenses, and a laser unit with a spot size of up to 7 mm. The axial length of the model eye was set to different values ranging from 20 to 31 mm, and the magnifications of the fundus imaging systems and the laser lenses were calculated and compared for a treatment spot with a diameter of 4 mm. The laser irradiance for treating the spot at different axial lengths was also recorded.


RESULTS
Whereas the magnification of a fundus imaging system is inversely related to the axial length, the laser spot size is directly related to axial length when using indirect condensing laser lenses. Therefore, the changes of magnification produced by axial ametropia are mostly compensated, so that the intended size of the treatment spot is obtained even in eyes with a high axial ametropia. The laser irradiance, on the other hand, has a significant variation for the observed range of the axial length.


CONCLUSIONS
Axial length has a significant effect on laser spot size and laser irradiance.


CONCLUSIONS
The effect of axial length on laser spot size and laser irradiance may be ignored when administering photodynamic therapy with verteporfin but has to be considered for transpupillary thermal treatment of choroidal neovascular lesions.
Stur
M
M
Department of Ophthalmology, University of Vienna Medical School, Allgemeines Krankenhaus, Währinger Gürtel 18-20/8i, A-1090 Vienna, Austria. michael.stur@akh-wien.ac.at
Ansari-Shahrezaei
S
S
D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000209:etiology; D005123:Eye / Q000033:anatomy & histology*; D006801:Humans; D007834:Lasers; D008268:Macular Degeneration / Q000150:complications; D008954:Models, Biological; D009887:Ophthalmoscopy; D010778:Photochemotherapy; D010781:Photography / Q000379:methods; D011166:Porphyrins / Q000627:therapeutic use; D000077362:Verteporfin
D011166:Porphyrins; D000077362:Verteporfin